Martin Shkreli, the disgraced CEO of drugmaker Turing Pharmaceuticals, resigned Friday from the company he founded following his arrest on unrelated securities fraud charges.<br />Ron Tilles, the chairman of the board of the privately held company, will serve as interim chief executive until a formal replacement is named, according to a Turing news release.<br />Federal prosecutors allege Shkreli orchestrated three interrelated fraud schemes from September 2009 through September 2014, using investors' money from one company he opened to illegally pay off debts owed to a previous business he started.
